
Fennec Pharmaceuticals Inc.
FENCHealthcare|Biotechnology|US
$9.81
+0.42 (+4.47%)
Tangible Book / Share
$1.23
Cash / Share
$1.19
Ownership Breakdown
48.4%
Float
35.1M
Shares Outstanding
17.0M
Float Shares
Major Holders (14)
Combined: 97.7%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | Corporation | 9.60% | 3,321,333 | Aug 13, 2026 | 13D/G |
| Aharon Gil | Individual | 9.40% | 3,188,001 | Aug 13, 2026 | 13D/G |
| Salamon Steven A J | Individual | 9.40% | 3,254,667 | Aug 13, 2026 | 13D/G |
| Rosalind Master Fund L.P. | Partnership | 9.20% | 3,188,001 | Aug 13, 2026 | 13D/G |
| Kam Lawrence | Individual | 8.20% | 2,799,959 | Feb 17, 2026 | 13D/G |
| Sonic Fund II, L.P. | Partnership | 7.60% | 2,607,357 | Feb 17, 2026 | 13D/G |
| Sonic GP LLC | Investment adviser | 7.60% | 2,607,357 | Feb 17, 2026 | 13D/G |
| AIGH Capital Management LLC | IA, OO | 7.10% | 2,499,421 | Oct 19, 2026 | 13D/G |
| Orin Hirschman | HC, IN | 7.10% | 2,499,421 | Oct 19, 2026 | 13D/G |
| Frederick Tucker Golden | HC, IN | 5.40% | 1,889,366 | Aug 14, 2026 | 13D/G |
| Solas Capital Management, LLC | IA, HC, OO | 5.40% | 1,889,366 | Aug 14, 2026 | 13D/G |
| Dov Gertzulin | HC, IN | 4.10% | 1,114,692 | Feb 14, 2025 | 13D/G |
| DG Capital Management, LLC | Investment adviser | 4.10% | 1,114,692 | Feb 14, 2025 | 13D/G |
| DG Value Partners II Master Fund, LP | Partnership | 3.50% | 953,407 | Feb 14, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 1,214,857 acquired · 418,111 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Evans Terry L | Chief Commercial Officer | Oct 31, 2026 | AWARD | 168 | — | — | Form 4 |
| Sayad Pierre Sargis | Chief Medical Officer | Oct 31, 2026 | AWARD | 168 | — | — | Form 4 |
| Hackman Jeffrey S. | director, officer: Chief Executive Officer | Oct 31, 2026 | AWARD | 1,159 | — | — | Form 4 |
| Cioffi Christiana Marie | Chief Strategy Officer | Oct 31, 2026 | AWARD | 156 | — | — | Form 4 |
| Andrade Robert | CHIEF FINANCIAL OFFICER | Oct 31, 2026 | AWARD | 1,703 | — | — | Form 4 |
| Sayad Pierre Sargis | Chief Medical Officer | Oct 12, 2026 | AWARD | 3,846 | $5.53 | $21.3K | Form 4 |
| Hackman Jeffrey S. | director, officer: Chief Executive Officer | Oct 12, 2026 | AWARD | 2,224 | $5.53 | $12.3K | Form 4 |
| Evans Terry L | Chief Commercial Officer | Oct 12, 2026 | AWARD | 2,326 | $5.53 | $12.9K | Form 4 |
| Cioffi Christiana Marie | Chief Strategy Officer | Oct 12, 2026 | AWARD | 3,946 | $5.53 | $21.8K | Form 4 |
| Andrade Robert | CHIEF FINANCIAL OFFICER | Oct 12, 2026 | AWARD | 3,846 | $5.53 | $21.3K | Form 4 |
| Sayad Pierre Sargis | Chief Medical Officer | Sep 30, 2026 | AWARD | 168 | — | — | Form 4 |
| Evans Terry L | Chief Commercial Officer | Sep 30, 2026 | AWARD | 168 | — | — | Form 4 |
| Hackman Jeffrey S. | director, officer: Chief Executive Officer | Sep 30, 2026 | AWARD | 1,159 | — | — | Form 4 |
| Cioffi Christiana Marie | Chief Strategy Officer | Sep 30, 2026 | AWARD | 156 | — | — | Form 4 |
| Andrade Robert | CHIEF FINANCIAL OFFICER | Sep 30, 2026 | AWARD | 1,703 | — | — | Form 4 |
| Brughera Marco Maria | director | Sep 15, 2026 | OPTION EX. | 15,545 | $2.11 | $32.8K | Form 4 |
| Brughera Marco Maria | director | Sep 15, 2026 | OPTION EX. | 15,545 | $2.11 | $32.8K | Form 4 |
| Brughera Marco Maria | director | Sep 15, 2026 | SELL | 15,545 | $10.29 | $160.0K | Form 4 |
| Raykov Rosty | other: Former Director | Aug 31, 2026 | AWARD | 2,778 | — | — | Form 4 |
| Raykov Rosty | other: Former Director | Sep 1, 2026 | SELL | 10,000 | $12.11 | $121.1K | Form 4 |
| Sayad Pierre Sargis | Chief Medical Officer | Aug 31, 2026 | AWARD | 168 | — | — | Form 4 |
| Sayad Pierre Sargis | Chief Medical Officer | Aug 31, 2026 | SELL | 12,000 | $12.18 | $146.2K | Form 4 |
| Evans Terry L | Chief Commercial Officer | Aug 31, 2026 | AWARD | 168 | — | — | Form 4 |
| Cioffi Christiana Marie | Chief Strategy Officer | Aug 31, 2026 | AWARD | 156 | — | — | Form 4 |
| Hackman Jeffrey S. | director, officer: Chief Executive Officer | Aug 31, 2026 | AWARD | 1,159 | — | — | Form 4 |
| Andrade Robert | CHIEF FINANCIAL OFFICER | Aug 31, 2026 | AWARD | 1,703 | — | — | Form 4 |
| Andrade Robert | CHIEF FINANCIAL OFFICER | Aug 28, 2026 | OPTION EX. | 21,928 | $5.10 | $111.8K | Form 4 |
| Andrade Robert | CHIEF FINANCIAL OFFICER | Aug 28, 2026 | OPTION EX. | 21,928 | $5.10 | $111.8K | Form 4 |
| Andrade Robert | CHIEF FINANCIAL OFFICER | Aug 27, 2026 | SELL | 75,000 | $11.78 | $883.5K | Form 4 |
| Raykov Rosty | other: Former Director | Aug 3, 2026 | SELL | 10,000 | $9.58 | $95.8K | Form 4 |
| Sayad Pierre Sargis | Chief Medical Officer | Jul 31, 2026 | AWARD | 168 | — | — | Form 4 |
| Evans Terry L | Chief Commercial Officer | Jul 31, 2026 | AWARD | 168 | — | — | Form 4 |
| Cioffi Christiana Marie | Chief Strategy Officer | Jul 31, 2026 | AWARD | 156 | — | — | Form 4 |
| Hackman Jeffrey S. | director, officer: Chief Executive Officer | Jul 31, 2026 | AWARD | 1,159 | — | — | Form 4 |
| Raykov Rosty | other: Former Director | Jul 31, 2026 | AWARD | 2,778 | — | — | Form 4 |
| Andrade Robert | CHIEF FINANCIAL OFFICER | Jul 31, 2026 | AWARD | 1,703 | — | — | Form 4 |
| Raykov Rosty | other: Former Director | Jul 1, 2026 | OPTION EX. | 15,597 | $2.45 | $38.2K | Form 4 |
| Raykov Rosty | other: Former Director | Jul 1, 2026 | OPTION EX. | 15,597 | $2.45 | $38.2K | Form 4 |
| Raykov Rosty | other: Former Director | Jul 1, 2026 | SELL | 9,599 | $10.41 | $99.9K | Form 4 |
| Raykov Rosty | other: Former Director | Jul 1, 2026 | AWARD | 2,778 | — | — | Form 4 |
| Evans Terry L | Chief Commercial Officer | Jun 30, 2026 | AWARD | 168 | — | — | Form 4 |
| Sayad Pierre Sargis | Chief Medical Officer | Jun 30, 2026 | AWARD | 168 | — | — | Form 4 |
| Hackman Jeffrey S. | director, officer: Chief Executive Officer | Jun 30, 2026 | AWARD | 1,159 | — | — | Form 4 |
| Andrade Robert | CHIEF FINANCIAL OFFICER | Jun 30, 2026 | AWARD | 1,703 | — | — | Form 4 |
| Cioffi Christiana Marie | Chief Strategy Officer | Jun 30, 2026 | AWARD | 156 | — | — | Form 4 |
| Brughera Marco Maria | director | Jun 10, 2026 | AWARD | 20,000 | $8.70 | $174.0K | Form 4 |
| Cook Jodi A | director | Jun 10, 2026 | AWARD | 20,000 | $8.70 | $174.0K | Form 4 |
| Islam Khalid | director | Jun 10, 2026 | AWARD | 25,000 | $8.70 | $217.5K | Form 4 |
| RALLIS CHRIS A | director | Jun 10, 2026 | AWARD | 20,000 | $8.70 | $174.0K | Form 4 |
| Raykov Rosty | director | Jun 1, 2026 | OPTION EX. | 15,597 | $2.45 | $38.2K | Form 4 |
| Raykov Rosty | director | Jun 1, 2026 | OPTION EX. | 15,597 | $2.45 | $38.2K | Form 4 |
| Raykov Rosty | director | Jun 1, 2026 | SELL | 9,747 | $9.62 | $93.8K | Form 4 |
| Raykov Rosty | director | May 31, 2026 | AWARD | 2,778 | — | — | Form 4 |
| Cioffi Christiana Marie | Chief Strategy Officer | May 31, 2026 | AWARD | 156 | — | — | Form 4 |
| Evans Terry L | Chief Commercial Officer | May 31, 2026 | AWARD | 168 | — | — | Form 4 |
| Sayad Pierre Sargis | Chief Medical Officer | May 31, 2026 | AWARD | 168 | — | — | Form 4 |
| Hackman Jeffrey S. | director, officer: Chief Executive Officer | May 31, 2026 | AWARD | 1,159 | — | — | Form 4 |
| Andrade Robert | CHIEF FINANCIAL OFFICER | May 31, 2026 | AWARD | 1,703 | — | — | Form 4 |
| RALLIS CHRIS A | director | May 11, 2026 | OPTION EX. | 14,344 | $2.44 | $35.0K | Form 4 |
| RALLIS CHRIS A | director | May 11, 2026 | OPTION EX. | 14,344 | $2.44 | $35.0K | Form 4 |
| RALLIS CHRIS A | director | May 11, 2026 | SELL | 8,346 | $7.04 | $58.8K | Form 4 |
| Raykov Rosty | director | May 1, 2026 | OPTION EX. | 15,598 | $2.45 | $38.2K | Form 4 |
| Raykov Rosty | director | May 1, 2026 | OPTION EX. | 15,598 | $2.45 | $38.2K | Form 4 |
| Raykov Rosty | director | May 1, 2026 | SELL | 10,781 | $6.47 | $69.8K | Form 4 |
| Raykov Rosty | director | Apr 30, 2026 | OPTION EX. | 2,778 | — | — | Form 4 |
| Evans Terry L | Chief Commercial Officer | Apr 30, 2026 | OPTION EX. | 168 | — | — | Form 4 |
| Cioffi Christiana Marie | Chief Strategy Officer | Apr 30, 2026 | OPTION EX. | 155 | — | — | Form 4 |
| Hackman Jeffrey S. | director, officer: Chief Executive Officer | Apr 30, 2026 | OPTION EX. | 1,159 | — | — | Form 4 |
| Andrade Robert | CHIEF FINANCIAL OFFICER | Apr 30, 2026 | OPTION EX. | 1,703 | — | — | Form 4 |
| Sayad Pierre Sargis | Chief Medical Officer | Apr 30, 2026 | OPTION EX. | 168 | — | — | Form 4 |
| Cioffi Christiana Marie | Chief Strategy Officer | Mar 31, 2026 | AWARD | 120,000 | $5.77 | $692.4K | Form 4 |
| Cioffi Christiana Marie | Chief Strategy Officer | Mar 28, 2026 | OPTION EX. | 1,901 | — | — | Form 4 |
| Cioffi Christiana Marie | Chief Strategy Officer | Mar 31, 2026 | OPTION EX. | 158 | — | — | Form 4 |
| Cioffi Christiana Marie | Chief Strategy Officer | Mar 31, 2026 | OPTION EX. | 17,106 | — | — | Form 4 |
| Hackman Jeffrey S. | director, officer: Chief Executive Officer | Mar 31, 2026 | AWARD | 200,000 | $5.77 | $1.2M | Form 4 |
| Hackman Jeffrey S. | director, officer: Chief Executive Officer | Mar 28, 2026 | OPTION EX. | 13,943 | — | — | Form 4 |
| Hackman Jeffrey S. | director, officer: Chief Executive Officer | Mar 31, 2026 | OPTION EX. | 1,159 | — | — | Form 4 |
| Hackman Jeffrey S. | director, officer: Chief Executive Officer | Mar 31, 2026 | OPTION EX. | 16,695 | — | — | Form 4 |
| Raykov Rosty | director | Apr 1, 2026 | OPTION EX. | 15,598 | $2.45 | $38.2K | Form 4 |
| Raykov Rosty | director | Apr 1, 2026 | OPTION EX. | 15,598 | $2.45 | $38.2K | Form 4 |
| Raykov Rosty | director | Apr 1, 2026 | SELL | 10,946 | $6.31 | $69.1K | Form 4 |
| Raykov Rosty | director | Mar 31, 2026 | AWARD | 5,208 | — | — | Form 4 |
| Sayad Pierre Sargis | Chief Medical Officer | Mar 31, 2026 | AWARD | 120,000 | $5.77 | $692.4K | Form 4 |
| Sayad Pierre Sargis | Chief Medical Officer | Mar 28, 2026 | OPTION EX. | 2,052 | — | — | Form 4 |
| Sayad Pierre Sargis | Chief Medical Officer | Mar 31, 2026 | OPTION EX. | 171 | — | — | Form 4 |
| Sayad Pierre Sargis | Chief Medical Officer | Mar 31, 2026 | OPTION EX. | 18,456 | — | — | Form 4 |
| Andrade Robert | CHIEF FINANCIAL OFFICER | Mar 31, 2026 | AWARD | 120,000 | $5.77 | $692.4K | Form 4 |
| Andrade Robert | CHIEF FINANCIAL OFFICER | Mar 28, 2026 | OPTION EX. | 12,270 | — | — | Form 4 |
| Andrade Robert | CHIEF FINANCIAL OFFICER | Mar 31, 2026 | OPTION EX. | 2,213 | — | — | Form 4 |
| Andrade Robert | CHIEF FINANCIAL OFFICER | Mar 31, 2026 | OPTION EX. | 14,724 | — | — | Form 4 |
| Evans Terry L | Chief Commercial Officer | Mar 31, 2026 | AWARD | 120,000 | $5.77 | $692.4K | Form 4 |
| Evans Terry L | Chief Commercial Officer | Mar 28, 2026 | OPTION EX. | 2,052 | — | — | Form 4 |
| Evans Terry L | Chief Commercial Officer | Mar 31, 2026 | OPTION EX. | 171 | — | — | Form 4 |
| Evans Terry L | Chief Commercial Officer | Mar 31, 2026 | OPTION EX. | 18,456 | — | — | Form 4 |
| Andrade Robert | CHIEF FINANCIAL OFFICER | Mar 26, 2026 | OPTION EX. | 13,072 | $5.10 | $66.7K | Form 4 |
| Andrade Robert | CHIEF FINANCIAL OFFICER | Mar 26, 2026 | OPTION EX. | 13,072 | $5.10 | $66.7K | Form 4 |
| Cioffi Christiana Marie | Chief Strategy Officer | Mar 26, 2026 | OPTION EX. | 4,700 | $4.23 | $19.9K | Form 4 |
| Cioffi Christiana Marie | Chief Strategy Officer | Mar 26, 2026 | OPTION EX. | 4,700 | $4.23 | $19.9K | Form 4 |
| Andrade Robert | CHIEF FINANCIAL OFFICER | Feb 28, 2026 | AWARD | 1,191 | — | — | Form 4 |
| Raykov Rosty | director | Mar 2, 2026 | OPTION EX. | 15,598 | $2.45 | $38.2K | Form 4 |